Shanghai Cancer Center, Fudan University
Shanghai Cancer Center, Fudan University
Shanghai, Shanghai Municipality, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors | Advanced Solid Tumors | Recruiting | Phase 2 | 2025-07-01 | NCT07046650 | |
| Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer | HER2-positive Breast Cancer | Recruiting | Not applicable | 2020-05-04 | NCT04281641 |